🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Bile Duct Diseases

Mapping Disease Pathways for Biliary Atresia NCT03273049n/a1 site📍 Pittsburgh University of Pittsburgh Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis NCT05335603n/a1 site📍 Hvidovre University of Copenhagen FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis NCT06286709Phase 25 sites📍 Birmingham📍 London📍 London University of Birmingham · Tests: Faecal Microbiota Transplant, FMT Placebo A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA NCT07282353Phase 342 sites📍 Hefei📍 Hefei📍 Hefei Cascade Pharmaceuticals, Inc · Tests: 2mg CS0159, Placebo Efficacy of Fistulotomy for Biliary Cannulation NCT04037007NA1 site📍 Mexico City Coordinación de Investigación en Salud, Mexico · Tests: Fistulotomy - High experienced., Fistulotomy - Low experienced., Conventional (guidewire) cannulation- High experienced… A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors NCT06043466Phase 12 sites📍 Hangzhou📍 Hangzhou Chongqing Precision Biotech Co., Ltd · Tests: CEA-targeted CAR-T cells Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE) NCT06315179n/a1 site📍 Seattle Seattle Children's Hospital · Tests: Esophagogastroduodenoscopy (EGD) with biopsy, Colonoscopy w/ biopsy Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma (POELH-III) NCT07161869n/a6 sites📍 Rotterdam📍 Amsterdam📍 Groningen Erasmus Medical Center · Tests: Registration of all findings during preoperative Endoscopic Ultrasound Austrian PBC Registry NCT07598669n/a11 sites📍 Klagenfurt📍 Sankt Pölten📍 Salzburg Medical University of Vienna Use of Indocyanine Green (ICG) for the Diagnosis of Biliary Atresia NCT07513038Phase 1, Phase 21 site📍 Boston Boston Children's Hospital · Tests: Indocyanine Green (ICG) Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma NCT05874414Phase 1, Phase 211 sites📍 Los Angeles📍 Los Angeles📍 Orlando Genfit · Tests: GNS561 + Trametinib ChOlecystectomy aFter successFul Endoscopic Common Bile Duct Stone Extraction in Elderly NCT07001423NA12 sites📍 Espoo📍 Hämeenlinna📍 Helsinki Helsinki University Central Hospital · Tests: Laparoscopic cholecystectomy Sequential Anti-Angiogenic Therapy After Immunotherapy in Advanced Biliary Tract Cancer NCT07025174Phase 21 site📍 Hangzhou First Affiliated Hospital of Zhejiang University · Tests: PD-1/CTLA-4 Dual Functional Antibody, Gemcitabine, Cisplatin, Anlotinib, Oxaliplatin + 5-Fluorouracil/Leucovorin Efficacy, Safety, and Tolerability of 4-MUST, 128 mg Tablets in Chronic Cholecystitis and Biliary Dyskinesia NCT07595003Phase 310 sites📍 Moscow📍 Moscow📍 Moscow Valenta Pharm JSC · Tests: 4-MUST, Placebo FIREFLY Trial: Fenofibrate Intervention---Randomized Evaluation in First-Line PBC Therapy NCT07296458Phase 31 site📍 Xi'an Xijing Hospital of Digestive Diseases · Tests: Fenofibrate, UDCA (Ursodeoxycholic acid) Early Diagnosis of Primary Biliary Cholangitis (PBC) in Patients With Positive Anti-Mitochondrial Antibodies (AMA) and Normal Alkaline Phosphatase (ALP) NCT07205874n/a1 site📍 Madrid Hospital Universitario La Paz PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI NCT05172310Phase 11 site📍 Stockholm Karolinska University Hospital · Tests: 68Ga-FAPI-46, PET/CT A Longitudinal Cohort Study on the Changes of Physiological Mechanisms in Children After Biliary Tract Reconstruction NCT07530354n/a3 sites📍 Wuhan📍 Wuhan📍 Wuhan Wuhan Children's Hospital Bile Omics for Diagnosing Indeterminate Biliary Strictures NCT07007832n/a1 site📍 Shanghai Shanghai General Hospital, Shanghai Jiao Tong University Sc… · Tests: Endoscopic retrograde cholangiopancreatography Preventive Effect of Prophylactic Oral Antibiotics Against Cholangitis After Kasai Portoenterostomy NCT05925309NA1 site📍 Shanghai Children's Hospital of Fudan University · Tests: Basic treatment: sulperazone + ursodeoxycholic acid + compound glycyrrhizin + methylprednisolone + vitamin AD , D , E ,… Long-Term Low-Intervention SafEty and Clinical Outcomes Clinical Study of LivmArli® in Patients With Alagille Syndrome or Progressive Familial Intrahepatic Cholestasis in the European Union (LEAP-EU) NCT07290257Phase 415 sites📍 Brussels📍 Ghent📍 Bron Mirum Pharmaceuticals, Inc. · Tests: Livmarli Oral Product BILACO Trial: Biliary Atresia - a Severe Complex Congenital Liver Disease NCT05399745n/a1 site📍 Copenhagen Copenhagen University Hospital, Rigshospitalet · Tests: Neurocognitive monitoring Clinical Trial Comparing ERCP vs ERCP and Transmural Gall Bladder Drainage NCT03921502NA1 site📍 Valladolid Hospital del Rio Hortega · Tests: Gall bladder transmural drainage with LAMS Liver Transplantation for Non-resectable Perihilar Cholangiocarcinoma NCT04993131NA1 site📍 Oslo Oslo University Hospital · Tests: Liver transplant MRI Based Biomarkers in Pediatric Autoimmune Liver Disease NCT03175471n/a1 site📍 Cincinnati Children's Hospital Medical Center, Cincinnati Nutritional Intervention for Biliary Atresia NCT06764082NA1 site📍 Wuhan Tongji Hospital · Tests: high MCT formula, normal oral intake of the traditional formula A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment NCT06850038n/a10 sites📍 Los Angeles📍 San Francisco📍 Kansas City Ipsen A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9 NCT07186842Phase 1, Phase 218 sites📍 Denver📍 Orlando📍 Detroit BioNTech SE · Tests: BNT329, CA19-9-targeting monoclonal antibody Impact of External Drainage of the Main Pancreatic Duct and Common Bile Duct on Pancreatic Fistula Following Pancreaticoduodenectomy NCT06322680NA1 site📍 Shanghai Shanghai Zhongshan Hospital · Tests: Main pancreatic duct and biliary duct external drainage, Main pancreatic duct and biliary duct internal drainage
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy